On Friday, Shares of Pfizer Inc. (NYSE:PFE), gained 0.06% to $35.19.
Pfizer and Synthon, an international pharmaceutical company specializing in the development of complex generic medicines, declared they have reached a contract whereby Pfizer has attained the exclusive commercialization rights in the United States to glatiramer acetate, a potential generic version of the originator medicine Copaxone® for the treatment of relapsing remitting multiple sclerosis (RRMS).
In November 2011, Synthon filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for a once daily 20mg/ml formulation of glatiramer acetate. In early 2014, Synthon filed an ANDA for a three times a week 40mg/ml formulation of glatiramer acetate with the FDA. In addition, Synthon believes its glatiramer acetate 40mg/ml filing may be eligible for 180 days of shared marketing exclusivity under the provisions of the Hatch-Waxman Act.
Under the terms of the agreement, Pfizer will have exclusive rights to commercialize both dosage formulations of Synthon’s glatiramer acetate in the United States. Synthon is responsible for the clinical development, manufacture and supply of glatiramer acetate. Pfizer is solely responsible for the commercialization of glatiramer acetate in the United States. Financial terms of the agreement were not revealed.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of Coca-Cola Enterprises Inc. (NYSE:CCE), declined -3.15% to $51.71, during its last trading session.
Coca-Cola Enterprises declared the appointment of Damian Gammell as Chief Operating Officer and the retirement of Hubert Patricot, President European Group in 2016.
Mr. Gammell will join the Company later this autumn from Anadolu Beverage Group, where he presently serves as President and Chief Executive Officer. Anadolu, based in Turkey, is one of the world’s largest beverage companies and owns Coca-Cola Icecek, one of the largest and fastest-growing bottlers of Coca-Cola products by sales volume. With operations across Eurasia, Anadolu serves more than 660 million consumers. He joined the Group in 2010 from The Coca-Cola Company, where he held CEO roles in Russia and Germany. During his 20-year career with the Coca-Cola system, Mr. Gammell has worked in Eastern Europe, Russia, Australia, Korea, Indonesia, Germany, Turkey and Pakistan, among other locations.
Mr. Gammell holds a Master of Science in change administration from Oxford University and HEC Paris. He has also accomplished programs at the Kennedy School of Government, Harvard University, and the Dublin Institute of Technology.
Coca-Cola Enterprises, Inc. produces, distributes, and markets non-alcoholic beverages in Belgium, continental France, Great Britain, Luxembourg, Monaco, the Netherlands, Norway, and Sweden.
Finally, Melco Crown Entertainment Limited (NASDAQ:MPEL), ended its last trade with 4.66% gain, and closed at $23.35.
Melco Crown Entertainment Limited stated its unaudited financial results for the second quarter of 2015.
Net revenue for the second quarter of 2015 was US$916.8 million, representing a decrease of about 24% from US$1,199.5 million for the comparable period in 2014. The decline in net revenue was primarily attributable to lower rolling chip revenues and mass market table games revenues in Macau, partially offset by the net revenue generated by City of Dreams Manila, which started operations in December 2014.
Adjusted property EBITDA(1) was US$204.9 million for the second quarter of 2015, as contrast to Adjusted property EBITDA of US$313.6 million in the second quarter of 2014. The 35% year-over-year decline in Adjusted property EBITDA was attributable to lower group-wide rolling chip volumes and rolling chip win rate, together with a lower contribution from the mass market table games segment.
On a U.S. GAAP basis, net income attributable to Melco Crown Entertainment for the second quarter of 2015 was US$24.3 million, or US$0.05 per ADS, contrast with net income attributable to Melco Crown Entertainment of US$143.6 million, or US$0.26 per ADS, in the second quarter of 2014. The net loss attributable to non-controlling interests during the second quarter of 2015 of US$30.0 million was related to Studio City and City of Dreams Manila.
Melco Crown Entertainment Limited, through its auxiliaries, develops, owns, and operates casino gaming and entertainment resort facilities in Asia. It owns and operates City of Dreams, an integrated casino resort that has 500 gaming tables and 1,400 gaming machines; about 1,400 hotel rooms and suites; a wet stage performance theater with about 2,000 seats; about 30 restaurants and bars, and 70 retail outlets; and recreation and leisure facilities, counting health and fitness clubs, swimming pools, spa and salons, and banquet and meeting facilities.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
